Corbenic Partners LLC Vertex Pharmaceuticals Inc Transaction History

Corbenic Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 14, 2021	SELL	$207.02 - $241.31 $12,007 - $13,995	-58 Closed	0 $0
Q3 2020 Oct 09, 2020	SELL	$255.65 - $303.1 $2,812 - $3,334	-11 Reduced 15.94%	58 $16,000
Q4 2019 Jan 14, 2020	BUY	$166.71 - $223.91 $11,502 - $15,449	69 New	69 $15,000
Q4 2017 Jan 25, 2018	SELL	$137.28 - $155.55 $10,707 - $12,132	-78 Closed	0 $0
Q3 2017 Oct 26, 2017	BUY	$148.13 - $162.24 $11,554 - $12,654	78	78 $12,000

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Corbenic Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Corbenic Partners LLC with notifications on news.